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Introduction
Gliomatosis peritonei is a rare disease, and is defined as
implantation of miliary glial tissue within the peritoneal
cavity in patients with ovarian teratoma [1]. The primary
ovarian teratoma may be mature or immature, but the
glial tissue is predominantly mature tissue and spreads
over the omentum, peritoneum and pelvis. Despite
widespread involvement of the peritoneal surface,
gliomatosis peritonei does not have a poor prognosis
even when associated with immature teratomas [2]. As
most patients with ovarian teratoma and gliomatosis
peritonei survive without adjuvant radio- or chemo-
therapy, it has generally been established that patients
with grade I primary tumors and grade 0 glial implants
do not require further therapy. Only 86 cases of this rare
entity have been reported [1]. Here, we report a case of
mature ovarian teratoma with gliomatosis and review
previous reports of this unusual phenomenon.
Case Report
A 36-year-old, gravida 4, para 2, woman was admitted
to our hospital with progression of abdominal distension
for 2 months. Intermittent fever up to 38$C was noted.
Transabdominal sonography revealed a heterogeneous
echo-complex mass measuring 20 = 13.1 = 9.5 cm in
the pelvis. Serum _-fetoprotein levels were within the
normal range, and CA-125 was 117.06 +/mL (upper
limit, 35 +/mL). Computed tomography (CT) scan
showed a pelvic mass measuring 18 = 10 = 10 cm, with
a cystic component and calcified spots (Figure 1). A
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fatty component, minimal ascites in the subhepatic
area, and irregularity of the peritoneum were also noted.
Immature teratoma with gliomatosis was suspected.
At laparotomy, a tumor of the right ovary, with an
intact capsule, was found. However, there were adhesion
bands between the tumor and the greater omentum
(Figure 2). Multiple gray-white firm nodules 0.1–0.3 cm
in diameter were noted in the pelvic peritoneum,
mesenteries, and omentum (Figure 3). Right salpingo-
oophorectomy and total omentectomy were performed,
with no complications. Multiple peritoneal biopsies
were also taken. Frozen section revealed mature cystic
teratoma. The paraffin report revealed mature cystic
teratoma composed of heterogeneous components,
including sebaceous substances, hair, cartilage, osseous
tissue, neuroglial components, connective tissue septa,
mucinous cyst and tooth-like structures. No immature
elements could be identified. The tumor seedings on the
omentum showed clear borders without infiltrative
margins. The pathology report of these omental and
peritoneal tumor seedings showed mature gliomatosis
(Figure 4). The picture of mature gliomatosis was also
present on the parietal and cul-de-sac peritoneum. One
of the three dissected omental lymph nodes also showed
gliomatosis (Figure 5).
The postoperative course was smooth. No further
chemotherapy was administered. The patient was
followed-up regularly at our clinic, and no evidence of
recurrence was found after 1 year.
Discussion
Gliomatosis peritonei is the implantation of glial tissue
on the peritoneal surfaces, usually in association with
solid ovarian teratomas. Criteria for grading of the
Figure 1. Computed tomography scan of the pelvis revealed a
pelvic mass with calcification (arrow) in the peritoneal cavity.
Figure 2. A right ovarian tumor (Ov, arrows) adhering to the
omentum was noted during surgery. Om = omentum; U =
uterus.
Figure 4. Diffuse gliomatosis (G) in the omentum was noted
under microscopy (hematoxylin & eosin, original magnification
= 33).
Figure 3. Multiple nodular gliomatosis (arrow) was noted on
the bowel surface, peritoneum and omentum.
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primary tumor and implants were first suggested by
Robboy and Scully [3]; these criteria were later modified
by Norris et al [4]. Patients who have immature ovarian
teratomas in association with mature glial implants
appear to have a much improved prognosis if peritoneal
surfaces and omentum, including diaphragmatic
surfaces, have been thoroughly sampled histologically;
and all of the implants are mature, i.e. there are no
immature elements [5]. Patients with grade I primary
tumor and grade 0 glial implants do not need further
therapy.
However, Shefren et al reported a patient with a
grade 3 immature teratoma who was found, on two
subsequent laparotomies, to have extensive peritoneal
implantation of mature glial tissue [6]. More than 5
years after the original surgery, she was found to have
a malignant abdominal glial neoplasm. The prognosis
for our patient, who had gliomatosis peritonei with
mature teratoma, may be better then the prognosis for
a patient with gliomatosis peritonei and immature
teratoma. However, regular follow-up was needed for
our patient.
To explain the pathogenesis of the glial tissue in
the peritoneal cavity, gliomatosis spread via capsular
defect or lymphatic metastasis has been discussed [1].
On the other hand, according to Dallenbach-Hellweg
[7], gliomatosis peritonei represents multiple primary
tumors, which, like a “field effect”, develop either
simultaneously or subsequently from pluripotent
subperitoneal Müllerian stem cells. Ferguson et al
extracted DNA samples from normal tissue, ovarian
teratoma tissue, and three glial implants in two patients
[8]. They found that glial implants in gliomatosis
peritonei often arise from cells within the peritoneum
and not from the associated ovarian teratoma. In our
patient, we found glial tissue in the adhesion band
between the primary tumor and omentum, and also in
an omental lymph node. We therefore considered that
the glial tissue came from the tumor and peritoneal
implantation occurred via lymphatic spread.
From Muller et al’s review of the literature, some
characteristics of gliomatosis peritonei were noted: the
highest incidence occurred in the first two decades of
life; there seems to be no preferred side; tumor adhesions
or capsule tears are reported in nearly 80% of cases;
the primary tumor may be of any grade, but a mature
or mainly well-differentiated teratoma seems to
predominate [1].
Ultrasonographic appearance of the teratoma is
characterized by echogenic sebaceous material and
calcification. On CT, fat attenuation within a cyst, with
or without calcification in the wall, is diagnostic of
cystic teratoma [9]. In our case, a heterogeneous
enhanced mass with spotty linear calcification and fatty
component in the pelvic cavity suggested that the pelvic
tumor was a teratoma. As the mass measured 18–20
cm, immature teratoma was the preferred diagnosis
because immature teratomas are typically larger (14–25
cm) than mature cystic teratomas (average, 7 cm) at
initial manifestation [9]. Immature teratomas may be
solid or have a prominent solid component with cystic
elements, and frequently demonstrate perforation of
the capsule. A large, irregular solid component
containing coarse calcifications and small foci of fat is
commonly seen, and hemorrhage is often present.
Minimal ascites in the subhepatic area and peritoneum
irregularity was noted in our patient on CT, so immature
teratoma with peritoneum metastasis or gliomatosis
was suspected before operation.
In summary, gliomatosis peritonei is a rare condition
and generally has a favorable prognosis. If patients un-
dergo extensive staging intraoperatively, the peritoneal
implants are well sampled, and histologic description
shows the implants to be completely mature, a benign
clinical course can be expected. A favorable outcome
for our patient was expected in view of previous cases.
However, further follow-up was needed.
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